Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Apiam Animal Health Ltd. ( (AU:AHX) ) just unveiled an update.
Apiam Animal Health Limited has lodged a Final Director’s Interest Notice for director Bruce Dixon, confirming that he holds no relevant interests in the company’s securities, either directly or indirectly, and has no interests in any related contracts. The filing indicates there are no shareholdings or contractual positions to disclose for this director, suggesting no immediate governance or ownership changes arising from his position in relation to the company’s capital structure.
This disclosure maintains transparency around director interests as required under ASX listing rules and the Corporations Act, supporting ongoing confidence in Apiam’s corporate governance and compliance practices. For shareholders and other stakeholders, the notice provides assurance that there are no undisclosed equity incentives or related-party contractual interests tied to this director that could affect oversight or alignment with investor interests.
The most recent analyst rating on (AU:AHX) stock is a Hold with a A$0.94 price target. To see the full list of analyst forecasts on Apiam Animal Health Ltd. stock, see the AU:AHX Stock Forecast page.
More about Apiam Animal Health Ltd.
Apiam Animal Health Limited operates in the veterinary and animal health sector, providing animal health services and products, with a focus on livestock and mixed animal practices across regional areas. The company services commercial producers and animal owners through its network of clinics and related operations in Australia.
Average Trading Volume: 261,151
Technical Sentiment Signal: Buy
Current Market Cap: A$164.4M
Find detailed analytics on AHX stock on TipRanks’ Stock Analysis page.

